Chemed Corp (CHE) stock
CHENYSEServices-Home Health Care ServicesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 17/306% above fair value
$546.75−2.70 (-0.49%)
Close on Nov 17, 2026Market cap $7.12BP/E 26.1Yield 0.40%
Chemed operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Chemed's operating income for the twelve months ending Sep 30, 2026 was $370.86M, up 5.5% year over year. For fiscal 2025 it was $338.25M, down 7.7% from the year before. Over ten years it grew 6.3% a year on average. The highest annual figure on record is $389.68M in fiscal 2020.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $338.25M | -7.7% |
| FY2024 | Dec 31, 2024 | $366.49M | +7.6% |
| FY2023 | Dec 31, 2023 | $340.57M | -0.9% |
| FY2022 | Dec 31, 2022 | $343.50M | +0.1% |
| FY2021 | Dec 31, 2021 | $343.04M | -12.0% |
| FY2020 | Dec 31, 2020 | $389.68M | +51.4% |
| FY2019 | Dec 31, 2019 | $257.38M | +5.6% |
| FY2018 | Dec 31, 2018 | $243.63M | +115.5% |
| FY2017 | Dec 31, 2017 | $113.04M | -36.8% |
| FY2016 | Dec 31, 2016 | $178.75M | -3.1% |
| FY2015 | Dec 31, 2015 | $184.46M | +9.5% |
| FY2014 | Dec 31, 2014 | $168.42M | +26.3% |
| FY2013 | Dec 31, 2013 | $133.39M | -14.7% |
| FY2012 | Dec 31, 2012 | $156.42M | +1.8% |
| FY2011 | Dec 31, 2011 | $153.73M | +7.1% |
| FY2010 | Dec 31, 2010 | $143.52M | +13.6% |
| FY2009 | Dec 31, 2009 | $126.35M | -4.9% |
| FY2008 | Dec 31, 2008 | $132.86M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $96.42M | +29.0% |
| Q2 FY2026 | Jun 30, 2026 | $89.20M | +31.0% |
| Q1 FY2026 | Mar 31, 2026 | $84.58M | -10.7% |
| Q4 FY2025 | Dec 31, 2025 | $100.65M | -11.6% |
| Q3 FY2025 | Sep 30, 2025 | $74.75M | -18.9% |
| Q2 FY2025 | Jun 30, 2025 | $68.08M | -22.7% |
| Q1 FY2025 | Mar 31, 2025 | $94.76M | +31.0% |
| Q4 FY2024 | Dec 31, 2024 | $113.88M | +2.2% |
| Q3 FY2024 | Sep 30, 2024 | $92.16M | +6.1% |
| Q2 FY2024 | Jun 30, 2024 | $88.13M | +26.8% |
| Q1 FY2024 | Mar 31, 2024 | $72.33M | -0.7% |
| Q4 FY2023 | Dec 31, 2023 | $111.39M | +37.0% |
| Q3 FY2023 | Sep 30, 2023 | $86.85M | +7.4% |
| Q2 FY2023 | Jun 30, 2023 | $69.51M | -24.4% |
| Q1 FY2023 | Mar 31, 2023 | $72.82M | -18.5% |
| Q4 FY2022 | Dec 31, 2022 | $81.33M | -17.0% |
| Q3 FY2022 | Sep 30, 2022 | $80.86M | -12.9% |
| Q2 FY2022 | Jun 30, 2022 | $91.94M | +28.2% |
| Q1 FY2022 | Mar 31, 2022 | $89.37M | +11.1% |
| Q4 FY2021 | Dec 31, 2021 | $98.03M | -31.6% |
| Q3 FY2021 | Sep 30, 2021 | $92.87M | +25.0% |
| Q2 FY2021 | Jun 30, 2021 | $71.70M | -22.7% |
| Q1 FY2021 | Mar 31, 2021 | $80.44M | +1.4% |
| Q4 FY2020 | Dec 31, 2020 | $143.25M | +85.0% |
| Q3 FY2020 | Sep 30, 2020 | $74.31M | +14.4% |
| Q2 FY2020 | Jun 30, 2020 | $92.76M | +41.6% |
| Q1 FY2020 | Mar 31, 2020 | $79.36M | +60.4% |
| Q4 FY2019 | Dec 31, 2019 | $77.45M | +14.9% |
| Q3 FY2019 | Sep 30, 2019 | $64.93M | +5.2% |
| Q2 FY2019 | Jun 30, 2019 | $65.53M | +12.7% |
| Q1 FY2019 | Mar 31, 2019 | $49.47M | -12.3% |
| Q4 FY2018 | Dec 31, 2018 | $67.38M | +19.2% |
| Q3 FY2018 | Sep 30, 2018 | $61.71M | +14.3% |
| Q2 FY2018 | Jun 30, 2018 | $58.14M | – |
| Q1 FY2018 | Mar 31, 2018 | $56.40M | +36.0% |
| Q4 FY2017 | Dec 31, 2017 | $56.53M | +6.4% |
| Q3 FY2017 | Sep 30, 2017 | $54.00M | – |
| Q2 FY2017 | Jun 30, 2017 | -$38.95M | – |
| Q1 FY2017 | Mar 31, 2017 | $41.45M | – |
| Q4 FY2016 | Dec 31, 2016 | $53.12M | – |
See a number that looks wrong?